Although GLP-1 receptor agonists have demonstrated effectiveness in reducing weight loss and risks for other chronic diseases, questions remain over whether the benefits outweigh the harms of the drugs, including their cost-effectiveness and economic impact, Hannah Moll, a PhD candidate from the department of epidemiology at the University of Zurich in Switzerland, and colleagues, wrote in eClinicalMedicine
Most patients continue treatment for several months to a year, depending on their progress and goals with some patients continuing to safely use their medication for multiple years
Body fat percentage, muscle mass, and overall metabolism can all play small roles in clearance time
speak to your GP to explore your options
doi: 10.1056/NEJMoa2107038
This will be a great physical indicator of your progression